14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

The immediate post-anaesthesia period represents an acute transition phase where protective physiological reflexes are restored. Discontinuing anaesthetic agents does not instantly return the patient to baseline homeostasis. Clinicians must safely manage emergence, recognize life-threatening upper airway obstruction, treat postoperative nausea and vomiting, and assess readiness for discharge.

---

1. Emergence from General Anaesthesia and Objective Extubation Criteria

Emergence is an active neurobiological process characterized by the progressive restoration of brainstem vegetative reflexes, subcortical arousal networks, and frontoparietal cortical connectivity.

                         [ SYSTEMATIC EXTUBATION CRITERIA ]
                                         |
        +--------------------------------+--------------------------------+
        |                                |                                |
  [ Ventilatory Mechanics ]      [ Neuromuscular Recovery ]      [ Neurological & Reflex Status ]
• Regular breathing pattern      • Quantitative TOF ratio        • Follows verbal commands
• Tidal volume > 5-6 mL/kg         >= 0.90 at adductor           • Sustained head lift > 5 s
• Respiratory rate 10-25/min       pollicis muscle               • Sustained strong hand grip
• SpO2 > 95% on FiO2 <= 0.4      • ZERO tactile fade is          • Intact swallowing reflex
• Normocapnia (EtCO2 normal)       INSUFFICIENT!                 • Active tongue protrusion

Objective Extubation Criteria

Extubation must be deferred until the patient meets all of the following physiological criteria:

1. Ventilatory Mechanics:
   • Spontaneous, regular respiratory rhythm.
   • Tidal volume ($V_T$) $> 5-6\text{ mL/kg}$ of ideal body weight.
   • Respiratory rate between $10$ and $25\text{ breaths/min}$.
   • Negative Inspiratory Force (NIF or $P_{i,\max}$) more negative than $-25\text{ to } -30\text{ cmH}_2\text{O}$.
2. Adequate Oxygenation and Gas Exchange:
   • $Sp\text{O}_2 > 95\%$ on $Fi\text{O}_2 \le 0.40$ (or patient's baseline room air saturation).
   • End-tidal $\text{CO}_2$ ($Et\text{CO}_2$) $< 45\text{ mmHg}$ ($< 6.0\text{ kPa}$) with stable arterial pH ($> 7.30$).
3. Quantitative Neuromuscular Recovery:
   • Recovery of a Train-of-Four (TOF) ratio $\ge 0.90$ documented quantitatively using acceleromyography, electromyography, or kinemyography at the adductor pollicis muscle.
   • Critical Rule: Clinical tests (5-second head lift, hand grip) and subjective visual/tactile assessment using a peripheral nerve stimulator cannot detect residual neuromuscular blockade (clinicians cannot reliably detect tactile TOF fade when the true TOF ratio is between $0.40$ and $0.80$). Residual curarization (TOF ratio < 0.90) causes upper esophageal collapse, impairs pharyngeal coordination, increases the risk of aspiration and postoperative pulmonary complications, and blunts the hypoxic ventilatory response.
4. Airway Protective Reflexes and Consciousness:
   • Return of swallowing, active coughing, and phonation.
   • Purposeful response to verbal commands (opening eyes, sustained hand grip $\ge 5\text{ seconds}$, head lift off pillow $\ge 5\text{ seconds}$).
   • Stable hemodynamics and core normothermia ($> 36.0^\circ\text{C}$). Hypothermia impairs drug metabolism and paralyzes platelet function.

Awake versus Deep Extubation

• Deep Extubation (Guedel Stage III, Plane 2): Tracheal tube is removed while the patient is deeply anesthetized under spontaneous breathing, before airway reflexes return. Advantages: Eliminates coughing, bucking, hemodynamic surges, and acute elevations in intraocular pressure (IOP), intracranial pressure (ICP), and surgical wound strain. Absolute Contraindications: Difficult airway, aspiration risk (full stomach, obesity, gastroesophageal reflux, hiatal hernia), prone or sitting surgery, impaired access to the airway, or morbid craniofacial distortion.
• Awake Extubation: Standard of care for difficult airways, aspiration risk, and unstable patients; performed only after the patient demonstrates purposeful command following and airway defense.

---

2. Emergence Complications: Laryngospasm, NPPE, and Shivering

Post-Extubation Laryngospasm

Laryngospasm is a sustained, involuntary reflex closure of the laryngeal musculature (primarily the lateral cricoarytenoid, transverse arytenoid, and thyroarytenoid adductor muscles) mediated by the internal branch of the superior laryngeal nerve (sensory afferent) and the recurrent laryngeal nerve (motor efferent) via the vagus nerve. It is triggered by blood, secretions, or surgical debris irritating the glottis during light anaesthesia (Guedel Stage II).

                      [ STEPWISE LARYNGOSPASM ESCALATION ]

   Step 1: 100% O2 + Larson's Maneuver (Firm Bilateral Jaw Thrust at Styloid Notch)
                                   |
                                   v (Spasm Persists)
   Step 2: Tight Face Mask Seal + CPAP (20 - 30 cmH2O)
                                   |
                                   v (Hypoxia / Persistent Spasm)
   Step 3: Deepen Anaesthesia: IV Propofol (0.5 - 1.0 mg/kg)
                                   |
                                   v (Severe Spasm / Desaturation)
   Step 4: Neuromuscular Blockade: IV Suxamethonium (0.1 - 0.5 mg/kg) + Atropine

1. Step 1 — Oxygen and Larson's Maneuver: Discontinue stimulation. Apply $100\%\text{ O}_2$. Perform Larson's maneuver (application of firm, sustained bilateral pressure directed anteriorly and medially into the "laryngospasm notch" behind the condyle of the mandible between the mastoid process and the ramus of the mandible; this intense periosteal stimulation breaks the adductor reflex arc while vigorously displacing the tongue and mandible anteriorly).
2. Step 2 — Continuous Positive Airway Pressure (CPAP): Apply a tight mask seal with $20-30\text{ cmH}_2\text{O}$ CPAP using the adjustable pressure-limiting (APL) valve. Continuous pressure splints the pharyngeal walls and pushes the false vocal cords laterally.
3. Step 3 — Pharmacological Deepening: Administer an intravenous bolus of propofol $0.5-1.0\text{ mg/kg}$ to suppress hyperactive brainstem reflexes.
4. Step 4 — Neuromuscular Blockade: If hypoxemia supervenes, administer low-dose suxamethonium $0.1-0.5\text{ mg/kg}$ IV (subparalytic dose that relaxes vocal cord adductors without requiring prolonged re-intubation). If IV access is lost, administer suxamethonium $2-4\text{ mg/kg}$ intramuscularly. In pediatric patients, pair with atropine $0.01-0.02\text{ mg/kg}$ to prevent suxamethonium-induced bradycardia.

Negative Pressure Pulmonary Edema (NPPE / Type I Post-Obstructive Pulmonary Edema)

NPPE occurs when a patient makes vigorous spontaneous inspiratory efforts against an acute upper airway obstruction (classic scenario: a young, muscular athletic male who develops post-extubation laryngospasm or bites the endotracheal tube upon emergence).

• Pathophysiology: Massive inspiratory efforts generate extreme negative intrathoracic pressures down to $-50\text{ to } -100\text{ cmH}_2\text{O}$ (normal quiet inspiration is $-3\text{ to } -5\text{ cmH}_2\text{O}$). This massive negative pressure markedly increases venous return to the right ventricle, elevates pulmonary capillary transmural hydrostatic pressure, and physically disrupts the tight junctions of the alveolar-capillary membrane ("alveolar stress failure"). Rapid transudation of fluid and erythrocytes floods the alveoli.
• Clinical Presentation: Acute respiratory distress, tachypnea, severe hypoxemia, bilateral diffuse alveolar infiltrates on chest radiograph, and copious pink, frothy pulmonary secretions appearing within minutes of relieving the obstruction.
• Management: Re-establish a patent airway. Apply high-concentration oxygen with continuous positive airway pressure (CPAP or PEEP $5-10\text{ cmH}_2\text{O}$ via face mask, or endotracheal re-intubation with mechanical ventilation). Clinical Pearl: NPPE is a non-cardiogenic, hydrostatic transudative edema in a typically euvolemic or hypovolemic patient; loop diuretics are not primarily indicated and can induce severe intravascular hypovolemia and hypotension. The disruption is temporary; with PEEP splinting, the edema clears spontaneously within $12-24\text{ hours}$.

Post-Anaesthetic Shivering

Occurs in up to $50\%$ of un-warmed recovery patients due to core-to-peripheral heat redistribution, inhibition of hypothalamic thermoregulation by volatile agents, and operative exposure.

• Physiological Hazards: Shivering dramatically increases whole-body oxygen consumption ($V\text{O}_2$) and carbon dioxide production ($V\text{CO}_2$) by $200-400\%$, precipitating myocardial ischemia in patients with coronary disease, metabolic lactic acidosis, and dangerous elevations in intraocular and intracranial pressure.
• Treatment: Active cutaneous forced-air warming blankets. Pharmacological interventions include meperidine (pethidine) $12.5-25\text{ mg}$ IV (the gold standard; acts on $\kappa$-opioid receptors to lower the shivering trigger threshold), tramadol $0.5-1.0\text{ mg/kg}$, clonidine $1-2\text{ }\mu\text{g/kg}$ IV ($\alpha_2$-agonist), or magnesium sulfate.

---

3. Postoperative Nausea and Vomiting (PONV): Risk Scores and Receptor Pharmacology

PONV is one of the most common distressing complications following anaesthesia, leading to dehydration, electrolyte disturbances, suture dehiscence, esophageal rupture (Boerhaave syndrome), and delayed hospital discharge.

The Apfel Risk Score

The Apfel simplified scoring system evaluates 4 independent clinical predictors, each assigning 1 point:

1. Female gender
2. Non-smoker status
3. History of PONV or motion sickness
4. Postoperative opioid administration

Neuroanatomy and Emetic Receptor Systems

Emesis is coordinated by the vomiting center in the lateral reticular formation of the medulla oblongata (including the Nucleus Tractus Solitarius / NTS), activated via four primary inputs:

1. Chemoreceptor Trigger Zone (CTZ): Located in the area postrema at the caudal floor of the 4th ventricle. Importantly, the area postrema lies outside the blood-brain barrier, allowing circulating toxins, emetogenic drugs (opioids, volatile anaesthetics), and metabolic byproducts direct access to CTZ receptors.
2. Vagal and Splanchnic Afferents: Gastrointestinal mucosal irritation and distension.
3. Vestibular System: Motion and middle ear surgery (via the 8th cranial nerve).
4. Higher Cortical Centers: Anticipatory nausea, anxiety, pain, and olfactory triggers.

                         [ NEUROANATOMY OF EMESIS ]

     [ Vestibular System ]                [ GI Vagal Afferents ]
      (H1 and M1 Receptors)               (5-HT3 and NK1 Receptors)
              \                                     /
               \                                   /
                v                                 v
      [ Chemoreceptor Trigger Zone ] ---> [ NUCLEUS TRACTUS SOLITARIUS ]
      (Area Postrema: D2, 5-HT3, NK1)     (Vomiting Center: M1, H1, NK1)
                                                        |
                                                        v
                                                  [ EMETIC REFLEX ]

Multimodal Antiemetic Pharmacology

Combining antiemetics with distinct mechanisms of action yields additive or synergistic efficacy:

---

4. PACU Discharge Criteria: The Modified Aldrete Score

Discharge from the post-anaesthesia care unit to the ward is based on objective criteria rather than a fixed length of stay. The Modified Aldrete score (Aldrete, 1995) replaced skin colour in the original score with pulse oximetry. Each of five domains scores 0 to 2, giving a maximum of 10:

• A score of 9 or more is the usual threshold for discharge from phase I recovery.
• The score does not assess pain, nausea, bleeding or the regional block level, so units add local criteria: controlled pain and PONV, a stable surgical site, adequate urine output where relevant, normothermia, and regression of neuraxial block before ward transfer.
• For day-case patients going home, the Post-Anaesthetic Discharge Scoring System (PADSS) scores vital signs, activity, nausea and vomiting, pain, and surgical bleeding (each 0 to 2), again using a threshold of 9 or more. Mandatory voiding before discharge is no longer required for most low-risk procedures.

---

5. Postoperative Delirium and Perioperative Neurocognitive Disorders

The 2018 multispecialty nomenclature groups postoperative cognitive problems as perioperative neurocognitive disorders:

• Postoperative delirium (POD): An acute, fluctuating disturbance of attention and awareness arising in hospital, usually within the first week after surgery (often in the first 72 hours).
• Delayed neurocognitive recovery: Cognitive decline identified up to 30 days after surgery.
• Postoperative neurocognitive disorder: Decline diagnosed between 30 days and 12 months; this replaces the research term postoperative cognitive dysfunction (POCD), which required formal neuropsychological testing.

Clinical Features and Screening

Delirium may be hyperactive (agitation, pulling at lines), hypoactive (quiet, drowsy, easily missed and associated with worse outcomes) or mixed. It is diagnosed with validated tools such as the Confusion Assessment Method (CAM), CAM-ICU in ventilated patients, the 4AT, or the Nursing Delirium Screening Scale (Nu-DESC). The ESAIC guideline on postoperative delirium (updated 2024) recommends screening at-risk patients from the recovery room and at least once per shift for several postoperative days.

Risk Factors and Prevention

• Predisposing factors: Older age, pre-existing cognitive impairment or dementia, frailty, sensory impairment, alcohol misuse, and high comorbidity burden.
• Precipitating factors: Emergency or major surgery, deep anaesthesia with burst suppression, benzodiazepines and anticholinergics (such as scopolamine), uncontrolled pain, hypoxaemia, sepsis, urinary retention, sleep deprivation, and electrolyte disturbance.
• Prevention: Multicomponent non-drug bundles (reorientation, glasses and hearing aids, early mobilisation, sleep hygiene, hydration), processed EEG-guided depth of anaesthesia to avoid excessive depth, avoidance of benzodiazepines where possible, opioid-sparing analgesia, and treating causes promptly. Antipsychotics are not recommended for routine prevention, and low-dose haloperidol is reserved for distressing agitation once reversible causes have been addressed.
• In the PACU, always exclude a physiological cause first: hypoxaemia, hypercapnia, hypoglycaemia, hypotension, a full bladder, pain, and residual neuromuscular blockade, which must be excluded with quantitative monitoring.